BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3284830)

  • 21. [Mucoregulators: specificity of carbocysteine].
    Beleslin DB
    Srp Arh Celok Lek; 1989; 117(5-6):371-7. PubMed ID: 2595466
    [No Abstract]   [Full Text] [Related]  

  • 22. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of seaprose on the rheology of bronchial mucus in patients with chronic bronchitis. A double-blind study vs placebo.
    Braga PC; Moretti M; Piacenza A; Montoli CC; Guffanti EE
    Int J Clin Pharmacol Res; 1993; 13(3):179-85. PubMed ID: 8225701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of lysine stepronin salts on mucociliary clearance].
    Olivieri D; Bernareggi V; Quitadamo M
    Arch Monaldi; 1985; 40(5-6):211-7. PubMed ID: 3843171
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sobrerol as expectorant in patients with stable chronic respiratory tract infections. A controlled study].
    Shang H; Grosgurin P; Medici TC
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1846-8. PubMed ID: 6760390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
    Martin R; Litt M; Marriott C
    Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of S-carboxymethylcysteine on the biophysical and biochemical properties of mucus in chronic bronchitics.
    Cox A; Jabbal-Gill I; Marriott C; Davis SS
    Adv Exp Med Biol; 1982; 144():423-9. PubMed ID: 7080939
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients.
    Ishiura Y; Fujimura M; Yamamori C; Nobata K; Myou S; Kurashima K; Michishita Y; Takegoshi T
    Br J Clin Pharmacol; 2003 Jun; 55(6):504-10. PubMed ID: 12814442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and tolerability of paracetamol-sobrerol combination in patients with hyperpyrexia].
    Marchioni CF; Gramolini C; Guerzoni P; Corona M; Corradini M
    Clin Ter; 1990 Oct; 135(2):105-13. PubMed ID: 2149543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 31. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
    Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical treatment of seromucous otitis].
    Renou G; Ketari M; Toutée JP; Benzaken J
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):327-8. PubMed ID: 8638061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
    Tatsumi K; Fukuchi Y;
    J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of a new drug combination in the therapy of acute and chronic bronchopneumopathies].
    Olivieri D; Pezza A; Polistina D; D'Agostino F
    Arch Monaldi; 1979; 34(1-2):29-41. PubMed ID: 554572
    [No Abstract]   [Full Text] [Related]  

  • 37. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
    Braga PC; Bossi R; Allegra L
    Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchial drainage prior to bronchography--a possible modification.
    Nigam BK
    Thorac Cardiovasc Surg; 1983 Feb; 31(1):49. PubMed ID: 6189253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.